We are live on ! Find out more
TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Fund
S&P 500
This Quarter Est. Return
+0.75%
1 Year Est. Return
+18.15%
3 Year Est. Return
+62.51%
5 Year Est. Return
+140.53%
10 Year Est. Return
+502.91%
AUM
$2.44B
AUM Growth
-$102M
Cap. Flow
-$54M
Cap. Flow %
-2.21%
Top 10 Hldgs %
38.65%
Holding
187
New
10
Increased
35
Reduced
38
Closed
19

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$45.2M
2
HUM icon
Humana
HUM
+$23.9M
3
LLY icon
Eli Lilly
LLY
+$20.3M
4
ILMN icon
Illumina
ILMN
+$20.1M
5
ABT icon
Abbott
ABT
+$17.5M

Top Sells

Rank Stock Value
1
MCK icon
McKesson
MCK
+$44.1M
2
UNH icon
UnitedHealth
UNH
+$23.9M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$23.1M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$21.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$21.3M

Sector Composition

Rank Sector Weight
1 Healthcare 96.9%
2 Real Estate 1.86%
3 Industrials 0.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ONC
101
BeOne Medicines Ltd
ONC
$32.6B
$2.83M 0.12%
20,952
-30,066
-59% -$5.16M
RARE icon
102
Ultragenyx Pharmaceutical
RARE
$2.46B
$2.78M 0.11%
67,065
+22,700
+51% +$1.17M
STE icon
103
Steris
STE
$22.7B
$2.77M 0.11%
16,669
– –
VTR icon
104
Ventas
VTR
$46.6B
$2.68M 0.11%
66,681
-181,450
-73% -$8.92M
WELL icon
105
Welltower
WELL
$168B
$2.67M 0.11%
41,484
-161,599
-80% -$12.6M
DOC
106
DELISTED
PHYSICIANS REALTY TRUST
DOC
$2.54M 0.1%
168,741
-326,992
-66% -$5.52M
PHG icon
107
Philips
PHG
$25.6B
$2.54M 0.1%
192,454
– –
CSII
108
DELISTED
Cardiovascular Systems, Inc.
CSII
$2.42M 0.1%
+174,859
New +$2.6M
MLTX icon
109
MoonLake Immunotherapeutics
MLTX
$1.48B
$2.39M 0.1%
+300,000
New +$2.12M
XENE icon
110
Xenon Pharmaceuticals
XENE
$6.02B
$2.23M 0.09%
61,733
+32,023
+108% +$1.15M
BCYC
111
Bicycle Therapeutics
BCYC
$270M
$2.06M 0.08%
88,676
+68,611
+342% +$1.63M
OPCH icon
112
Option Care Health
OPCH
$3.55B
$2.04M 0.08%
+64,975
New +$2.08M
IDYA icon
113
IDEAYA Biosciences
IDYA
$3.41B
$1.99M 0.08%
+133,185
New +$1.73M
EWTX icon
114
Edgewise Therapeutics
EWTX
$4.13B
$1.92M 0.08%
195,025
+134,475
+222% +$1.36M
ICLR icon
115
Icon
ICLR
$12.2B
$1.92M 0.08%
10,434
-70,941
-87% -$15.4M
RXDX
116
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$1.86M 0.08%
31,505
-17,690
-36% -$809K
PRGO icon
117
Perrigo
PRGO
$1.48B
$1.83M 0.07%
51,224
– –
GRTX
118
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.56M 0.06%
898,374
– –
XRN
119
Chiron Real Estate Inc
XRN
$467M
$1.49M 0.06%
34,979
– –
MEDP icon
120
Medpace
MEDP
$16B
$1.48M 0.06%
9,435
– –
ZLAB icon
121
Zai Lab
ZLAB
$2.05B
$1.48M 0.06%
43,300
– –
PYXS icon
122
Pyxis Oncology
PYXS
$193M
$1.4M 0.06%
708,303
– –
TAK icon
123
Takeda Pharmaceutical
TAK
$53.7B
$1.36M 0.06%
105,073
– –
MREO
124
Mereo BioPharma
MREO
$50.4M
$1.34M 0.05%
1,551,082
– –
MORF
125
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.26M 0.05%
44,625
– –
3 4
5
6 7

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
BWM
BerganKDV Wealth Management Bloomington, Minnesota $1,000M AUM 9.95% 1-Year Est. Return

Tekla Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Tekla Capital Management held 187 positions worth $2.44B, down 4% from $2.54B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Tekla Capital Management's Q3 2022 filing shows 10 new, 35 increased, 38 reduced and 19 closed positions. Its largest new stake was Veradigm Inc. Common Stock: 428,580 shares worth $6.53M. The largest sale was McKesson, an estimated $44.1M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 95% a quarter earlier, followed by Real Estate and Industrials.

  • Tekla Capital Management's largest Q3 2022 buy was Veradigm Inc. Common Stock: 428,580 shares worth $6.53M.
  • Tekla Capital Management added most to Johnson & Johnson in Q3 2022, an estimated $45.2M increase.
  • Tekla Capital Management's biggest Q3 2022 reduction was McKesson, cutting an estimated $44.1M.
  • Tekla Capital Management fully exited Syneos Health, Inc. Class A Common Stock in Q3 2022, selling an estimated $21.7M.
  • Tekla Capital Management's ten largest holdings make up 39% of its $2.44B portfolio in Q3 2022.
  • Tekla Capital Management opened 10 new positions and closed 19 in Q3 2022.
  • Tekla Capital Management's portfolio value fell 4% quarter-over-quarter to $2.44B.

Based on Tekla Capital Management's 13F filing for Q3 2022, filed 1 Nov 2022.